| 0.467 | 0.004 | 0.467 | Nav1.3 sodium channel blocker | | |
| 0.354 | 0.002 | 0.354 | Sodium/hydrogen exchanger inhibitor | | |
| 0.273 | 0.027 | 0.273 | Diuretic | | |
| 0.262 | 0.068 | 0.262 | Platelet antagonist | | |
| 0.257 | 0.078 | 0.257 | Cardiotonic | | |
| 0.213 | 0.037 | 0.213 | Acetylcholine M1 receptor antagonist | | |
| 0.2 | 0.032 | 0.2 | Sodium channel blocker | | |
| 0.282 | 0.13 | 0.282 | Antiobesity | | |
| 0.158 | 0.02 | 0.158 | Alpha 2a adrenoreceptor antagonist | | |
| 0.162 | 0.028 | 0.162 | Bronchodilator | | |
| 0.148 | 0.016 | 0.148 | 5 Hydroxytryptamine uptake inhibitor | | |
| 0.159 | 0.033 | 0.159 | Antiadrenergic | | |
| 0.135 | 0.011 | 0.135 | Adrenaline uptake inhibitor | | |
| 0.155 | 0.033 | 0.155 | Adrenaline antagonist | | |
| 0.248 | 0.127 | 0.248 | Antithrombotic | | |
| 0.128 | 0.008 | 0.128 | Glycine transporter inhibitor | | |
| 0.135 | 0.019 | 0.135 | Adrenaline agonist | | |
| 0.118 | 0.005 | 0.118 | Glycine transporter 1 inhibitor | | |
| 0.136 | 0.025 | 0.136 | Neuropeptide Y antagonist | | |
| 0.108 | 0.01 | 0.108 | Dopamine transporter inhibitor | | |
| 0.098 | 0.003 | 0.098 | Phenylethanolamine N methyltransferase inhibitor | | |
| 0.105 | 0.015 | 0.105 | Bcl2 antagonist | | |
| 0.12 | 0.037 | 0.12 | Alpha 2 adrenoreceptor antagonist | | |
| 0.107 | 0.025 | 0.107 | Dopamine agonist | | |
| 0.131 | 0.066 | 0.131 | CC chemokine 6 receptor antagonist | | |
| 0.122 | 0.063 | 0.122 | 5 Hydroxytryptamine antagonist | | |
| 0.111 | 0.054 | 0.111 | Chemokine receptor antagonist | | |
| 0.087 | 0.035 | 0.087 | Epoxide hydrolase inhibitor | | |
| 0.07 | 0.019 | 0.07 | Bcl-xL inhibitor | | |
| 0.103 | 0.055 | 0.103 | Alpha adrenoreceptor antagonist | | |
| 0.159 | 0.118 | 0.159 | Platelet aggregation inhibitor | | |
| 0.068 | 0.027 | 0.068 | Thromboxane antagonist | | |
| 0.065 | 0.024 | 0.065 | Thromboxane A2 antagonist | | |
| 0.085 | 0.047 | 0.085 | CC chemokine receptor antagonist | | |
| 0.108 | 0.071 | 0.108 | Nav1.5 sodium channel blocker | | |
| 0.132 | 0.096 | 0.132 | Neuropeptide Y1 antagonist | | |
| 0.087 | 0.052 | 0.087 | Histamine H2 receptor antagonist | | |
| 0.078 | 0.044 | 0.078 | Vanilloid 4 agonist | | |
| 0.068 | 0.036 | 0.068 | Cannabinoid CB1 receptor antagonist | | |
| 0.065 | 0.033 | 0.065 | 5 Hydroxytryptamine 6 antagonist | | |
| 0.091 | 0.063 | 0.091 | Antihistaminic | | |
| 0.048 | 0.028 | 0.048 | Dopamine D2 agonist | | |
| 0.081 | 0.062 | 0.081 | Histamine antagonist | | |
| 0.069 | 0.051 | 0.069 | Cannabinoid receptor antagonist | | |
| 0.068 | 0.051 | 0.068 | 5 Hydroxytryptamine 1F antagonist | | |
| 0.06 | 0.045 | 0.06 | Dopamine D3 antagonist | | |
| 0.049 | 0.037 | 0.049 | Beta 2 adrenoreceptor antagonist | | |
| 0.089 | 0.077 | 0.089 | Electrolyte absorption antagonist | | |
| 0.057 | 0.048 | 0.057 | 5 Hydroxytryptamine 7 antagonist | | |
| 0.067 | 0.057 | 0.067 | Dopamine antagonist | | |
| 0.052 | 0.047 | 0.052 | Dopamine uptake inhibitor | | |
| 0.094 | 0.09 | 0.094 | Adenylate cyclase inhibitor | | |
| 0.056 | 0.052 | 0.056 | Dopamine D2 antagonist | | |
| 0.196 | 0.192 | 0.196 | Calpain 2 inhibitor | | |
| 0.06 | 0.056 | 0.06 | Beta adrenoreceptor antagonist | | |
| 0.131 | 0.129 | 0.131 | Platelet adhesion inhibitor | | |
| 0.021 | 0.019 | 0.021 | Epoxide hydrolase 2 inhibitor | | |
| 0.037 | 0.035 | 0.037 | Dopamine D5 antagonist | | |